| scholarly article | Q13442814 |
| P50 | author | Graham J Lieschke | Q55149847 |
| P2093 | author name string | A R Dunn | |
| D Metcalf | |||
| J Cebon | |||
| D Grail | |||
| E Stanley | |||
| G Hodgson | |||
| J A Gall | |||
| D W Maher | |||
| V Sinickas | |||
| P2860 | cites work | Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene | Q28512170 |
| A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor | Q33559130 | ||
| Molecular physiology of granulocyte-macrophage colony-stimulating factor | Q34088391 | ||
| Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor | Q36361789 | ||
| Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes | Q36487771 | ||
| Lineage commitment of hemopoietic progenitor cells in developing blast cell colonies: influence of colony-stimulating factors | Q37645054 | ||
| Hematopoietic regulators: redundancy or subtlety? | Q40790177 | ||
| The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: evidence for utilisation of alternative promoters | Q41420689 | ||
| Differential inhibition by cyclosporin A reveals two pathways for activation of lymphokine synthesis in T cells | Q46462469 | ||
| Inflammatory Responses to Pneumocystis carinii in Mice Selectively Depleted of Helper T Lymphocytes | Q46600247 | ||
| Pulmonary Alveolar Proteinosis | Q55980205 | ||
| Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage | Q57240770 | ||
| Hemopoietic responses in mice injected with purified recombinant murine GM-CSF | Q68809110 | ||
| Rat tracheal epithelial cells produce granulocyte/macrophage colony-stimulating factor | Q68931182 | ||
| Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule | Q70452024 | ||
| Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis | Q70532435 | ||
| Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies | Q71650396 | ||
| A cell-surface antigen shared by B cells and Ly2+ peripheral T cells | Q72115602 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| macrophage | Q184204 | ||
| hemopoiesis | Q919283 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 5592-5596 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology | |
| P478 | volume | 91 |
| Q44601893 | 15-Deoxy-delta 12,14-prostaglandin J2 inhibits the expression of granulocyte-macrophage colony-stimulating factor in endothelial cells stimulated with lipopolysaccharide |
| Q35351495 | 5-Azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival |
| Q36543836 | 5. Mechanisms of disordered granulopoiesis in congenital neutropenia |
| Q37018307 | A (selective) history of Australian involvement in cytokine biology |
| Q26774775 | A Review of GM-CSF Therapy in Sepsis |
| Q38685636 | A Semiquantitative Computed Tomographic Grading System for Evaluating Therapeutic Response in Pulmonary Alveolar Proteinosis. |
| Q42007592 | A T Cell View of the Bone Marrow |
| Q101477993 | A cell-centric view of lung alveologenesis |
| Q27345215 | A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth |
| Q46358328 | A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP). |
| Q34032594 | A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit |
| Q51710520 | A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. |
| Q28586895 | A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation |
| Q35803316 | A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus |
| Q53528634 | ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. |
| Q28273478 | AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis |
| Q74495523 | Acute respiratory failure caused by secondary alveolar proteinosis in a patient with acute myeloid leukemia: a case report |
| Q91260456 | Alpha-hemolysin of uropathogenic Escherichia coli induces GM-CSF-mediated acute kidney injury |
| Q30156952 | Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. |
| Q36971475 | Alveolar Epithelial Cell-Derived Prostaglandin E2 Serves as a Request Signal for Macrophage Secretion of Suppressor of Cytokine Signaling 3 during Innate Inflammation. |
| Q31157006 | Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection |
| Q35101037 | Alveolar proteinosis in a patient recovering from Pneumocystis carinii infection: a case report with a review of literature |
| Q28261260 | Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease |
| Q29615498 | An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow |
| Q37418292 | An open-label trial of rituximab therapy in pulmonary alveolar proteinosis |
| Q43058950 | Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis |
| Q22011170 | Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation |
| Q90312369 | Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation |
| Q53894176 | Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. |
| Q37072048 | Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice. |
| Q38049370 | Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013. |
| Q24290960 | Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice |
| Q36060847 | Biallelic Mutations of Methionyl-tRNA Synthetase Cause a Specific Type of Pulmonary Alveolar Proteinosis Prevalent on Réunion Island |
| Q52604134 | CCL17 blockade as a therapy for osteoarthritis pain and disease. |
| Q57112440 | CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons |
| Q37999076 | CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways |
| Q38218871 | CSF-1R signaling in health and disease: a focus on the mammary gland. |
| Q28507518 | Cationic amino acid transporter 2 regulates inflammatory homeostasis in the lung |
| Q51093849 | Cell-cell signalling in the regulation of blood cell formation and function. |
| Q34004612 | Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion |
| Q28509813 | Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice |
| Q24657836 | Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan |
| Q41033271 | Chemotherapy and neutropenia |
| Q73879537 | Circadian rhythm of granulocyte-macrophage colony-stimulating factor in normal subjects and neutropenic hospitalised patients |
| Q34244200 | Clinical biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism |
| Q33680122 | Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population |
| Q36203148 | Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis |
| Q43068695 | Clinical uses of GM-CSF, a critical appraisal and update |
| Q37190439 | Colony-stimulating factors in inflammation and autoimmunity. |
| Q28348147 | Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1) |
| Q33194891 | Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis |
| Q28138504 | Compound SFTPB 1549C-->GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiency |
| Q36371058 | Constitutive activation of the SRC family kinase Hck results in spontaneous pulmonary inflammation and an enhanced innate immune response |
| Q62817943 | Constitutive overexpression of TNF in BPSM1 mice causes iBALT and bone marrow nodular lymphocytic hyperplasia |
| Q54576649 | Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. |
| Q37693083 | Crossing paths: interactions between the cell death machinery and growth factor survival signals |
| Q28590729 | Csf2 null mutation alters placental gene expression and trophoblast glycogen cell and giant cell abundance in mice |
| Q39360158 | Cytokine gene expression profile in monocytic cells after a co-culture with epithelial cells. |
| Q36970182 | Cytokine receptors and hematopoietic differentiation |
| Q36375400 | Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/macrophage colony-stimulating factor |
| Q41165211 | Cytokines and production of surfactant components |
| Q35074547 | Cytokines and the immune-testicular axis |
| Q47912530 | Cytokines in hematopoiesis |
| Q64008502 | Cytokines in hematopoiesis: specificity and redundancy in receptor function |
| Q41022590 | Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor beta chain (hbetac) responsible for human GM-CSF-induced myeloid cell differentiation |
| Q33766421 | Cytosolic phospholipase a2 activation by Candida albicans in alveolar macrophages: role of dectin-1. |
| Q36377402 | Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor |
| Q61955139 | Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor |
| Q34157406 | Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies. |
| Q35753538 | Development of secreted proteins as biotherapeutic agents |
| Q44773983 | Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia |
| Q34336416 | Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism |
| Q40547290 | Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia |
| Q37424817 | Distinct progenitor origin distinguishes a lineage of dendritic-like cells in spleen |
| Q27002464 | Distinct regulation of dengue virus-induced inflammasome activation in human macrophage subsets |
| Q37367171 | Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia |
| Q37039002 | Dynamics of lung macrophage activation in response to helminth infection. |
| Q37388105 | Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice |
| Q53761467 | Effect of granulocyte-macrophage colony-stimulating factor on the number of leucocytes and course of Listeria monocytogenes infection in naive and leucocytopenic mice. |
| Q35782608 | Effects of macrophage colony-stimulating factor on macrophages and their related cell populations in the osteopetrosis mouse defective in production of functional macrophage colony-stimulating factor protein |
| Q36284490 | Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile. |
| Q79184205 | Elevated IL-10 Inhibits GM-CSF Synthesis in Pulmonary Alveolar Proteinosis |
| Q38206076 | Emergency granulopoiesis |
| Q34106812 | Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis |
| Q36370397 | Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion |
| Q35061752 | Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice |
| Q37118186 | Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines |
| Q42623970 | Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis |
| Q36979961 | Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. |
| Q46357118 | Fertility impairment in granulocyte-macrophage colony-stimulating factor-deficient mice. |
| Q42063604 | FoxP3+ regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells |
| Q34359869 | From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation |
| Q40596439 | Frontline Science: Coincidental null mutation of Csf2rα in a colony of PI3Kγ-/- mice causes alveolar macrophage deficiency and fatal respiratory viral infection |
| Q36022709 | Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation |
| Q30366001 | Functional significance of mononuclear phagocyte populations generated through adult hematopoiesis |
| Q37607068 | G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis |
| Q26800954 | G-CSF and GM-CSF in Neutropenia |
| Q28554454 | GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes |
| Q58698466 | GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function |
| Q30476295 | GM-CSF action in the CNS decreases food intake and body weight |
| Q30835058 | GM-CSF and IL-3 Modulate Human Monocyte TNF-α Production and Renewal in In Vitro Models of Trained Immunity. |
| Q41870391 | GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity |
| Q38369816 | GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential. |
| Q47138480 | GM-CSF as a therapeutic target in autoimmune diseases |
| Q36398839 | GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells |
| Q82224165 | GM-CSF deficiency delays neointima formation in a normolipidemic mouse model of endoluminal endothelial damage |
| Q90701013 | GM-CSF in inflammation |
| Q34754737 | GM-CSF in inflammation and autoimmunity. |
| Q43481101 | GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice |
| Q36916371 | GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival |
| Q42844958 | GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice |
| Q37778844 | GM-CSF pathway correction in pulmonary alveolar proteinosis |
| Q40242340 | GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS. |
| Q55303373 | GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection. |
| Q90265818 | GM-CSF-Dependent Inflammatory Pathways |
| Q96640469 | GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches |
| Q33842816 | GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection |
| Q34058590 | GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen. |
| Q28080640 | GM-CSF: An immune modulatory cytokine that can suppress autoimmunity |
| Q42616336 | GM-CSF: a role in immune and inflammatory reactions in the intestine |
| Q95823976 | Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model |
| Q77903163 | General classes and functions of four-helix bundle cytokines |
| Q24626239 | Genetic interstitial lung disease |
| Q40382136 | Genetic knockouts in mice: an update |
| Q28388821 | Genetically manipulated mouse models of lung disease: potential and pitfalls |
| Q35820983 | Granulocyte colony-stimulating factor and leukemogenesis. |
| Q41101389 | Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis |
| Q73676636 | Granulocyte macrophage colony stimulating factor (GM-CSF) activity is regulated by a GM-CSF binding molecule in Wallerian degeneration following injury to peripheral nerve axons |
| Q34457373 | Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions |
| Q42944465 | Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. |
| Q33302233 | Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis |
| Q36394962 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know |
| Q40639060 | Granulocyte-macrophage colony-stimulating factor (GM-CSF) is released by female mouse bladder urothelial cells and expressed by the urothelium as an early response to lipopolysaccharides (LPS). |
| Q45285614 | Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis |
| Q33551339 | Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis |
| Q39570156 | Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis. |
| Q46929817 | Granulocyte-macrophage colony-stimulating factor in amniotic fluid and in airway specimens of newborn infants |
| Q41699299 | Granulocyte-macrophage colony-stimulating factor increases surfactant phospholipid in premature rabbits |
| Q36633120 | Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development. |
| Q42503353 | Granulocyte-macrophage colony-stimulating factor is essential for normal wound healing |
| Q43547982 | Granulocyte-macrophage colony-stimulating factor promotes glucose transport and blastomere viability in murine preimplantation embryos |
| Q34005519 | Granulocyte-macrophage colony-stimulating factor-deficient mice have impaired resistance to blood-stage malaria |
| Q36403358 | Granulocyte/macrophage colony-stimulating factor and accessory cells modulate radioprotection by purified hematopoietic cells |
| Q35745319 | Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation |
| Q37129681 | Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects |
| Q39242434 | Growth Factor Regulation in the Nephrogenic Zone of the Developing Kidney |
| Q41689649 | Growth factors and hematopoietic stem cells |
| Q24799022 | Growth factors in lung development and disease: friends or foe? |
| Q52538767 | Haemopoiesis in mice genetically lacking granulocyte-macrophage colony stimulating factor during chronic infection with Mycobacterium avium. |
| Q33853579 | Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. |
| Q34734185 | Hematopoietic cytokines |
| Q41193269 | Hematopoietic effects and clinical application of granulopoietic growth factors |
| Q34402453 | Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy |
| Q34573221 | Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung |
| Q42503158 | Human alveolar macrophages and granulocyte-macrophage colony-stimulating factor-induced monocyte-derived macrophages are resistant to H2O2 via their high basal and inducible levels of catalase activity |
| Q33995307 | Human hemato-lymphoid system mice: current use and future potential for medicine |
| Q28139629 | Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation |
| Q24316176 | Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression |
| Q38112353 | IL-34 and CSF-1: similarities and differences |
| Q42514540 | IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. |
| Q34979530 | Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling |
| Q37771906 | Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis |
| Q43650913 | Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia |
| Q35143094 | Immunomodulatory effects of quinolones |
| Q43756046 | Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis. |
| Q41429411 | Impact of knockout mice in toxicology |
| Q64110652 | Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease |
| Q33950106 | Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis |
| Q64255636 | Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease |
| Q38932181 | Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity |
| Q38468658 | Innate response activator B cells: origins and functions |
| Q36416397 | Integrin beta6 mediates phospholipid and collectin homeostasis by activation of latent TGF-beta1. |
| Q37377903 | Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. |
| Q36131723 | Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. |
| Q37375089 | Is Cryptococcus gattii a Primary Pathogen? |
| Q34869806 | Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages |
| Q40409394 | Knockouts. Targeting the mouse genome: a compendium of knockouts (Part I) |
| Q35769439 | Lineage commitment and developmental plasticity in early lymphoid progenitor subsets |
| Q41241667 | Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia |
| Q51136551 | Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose. |
| Q48026318 | Lung disease: Treatment by cell transplant |
| Q37218071 | Lung environment determines unique phenotype of alveolar macrophages |
| Q26740162 | Lung epithelial GM-CSF improves host defense function and epithelial repair in influenza virus pneumonia-a new therapeutic strategy? |
| Q34145236 | Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors |
| Q53274292 | MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer. |
| Q35826586 | MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. |
| Q37077690 | Macrophage differentiation and function in health and disease |
| Q37521345 | Macrophages and CSF-1: implications for development and beyond |
| Q63915886 | Macrophages and Cardiovascular Health |
| Q27007092 | Macrophages: gatekeepers of tissue integrity |
| Q40563569 | Management of pulmonary alveolar proteinosis by repeated bronchoalveolar lavage. |
| Q37315900 | Mast cells are required for full expression of allergen/SEB-induced skin inflammation |
| Q34411088 | Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis |
| Q54035383 | Mice unresponsive to GM-CSF are unexpectedly resistant to cutaneous Leishmania major infection. |
| Q55355299 | Microbiota and immune cell crosstalk: dialogues driving health and disease. |
| Q49447486 | Model-Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab |
| Q47911167 | Molecular and cellular events in early thymocyte development |
| Q41763168 | Molecular basis of in vitro affinity maturation and functional evolution of a neutralizing anti-human GM-CSF antibody |
| Q29547438 | Monocyte and macrophage heterogeneity |
| Q37726689 | Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death |
| Q58478781 | Mouse macrophage development in the absence of the common γ chain: defining receptor complexes responsible for IL-4 and IL-13 signaling |
| Q40241909 | Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines |
| Q24541648 | Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis |
| Q89876422 | NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS |
| Q89660035 | Natural Autoantibodies in Chronic Pulmonary Diseases |
| Q40922914 | Neutropenia in the neonate. |
| Q34092240 | Neutrophil kinetics in health and disease. |
| Q38310658 | Neutrophil migration under normal and sepsis conditions |
| Q38665014 | Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. |
| Q36938511 | Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists |
| Q33908222 | Origins and functions of phagocytes in the embryo |
| Q35743143 | Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study |
| Q41526360 | Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies |
| Q36121727 | PPARs in alveolar macrophage biology |
| Q33889234 | PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors |
| Q44535674 | PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor |
| Q33988125 | Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates |
| Q44477055 | Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis |
| Q37237437 | Pertussis toxin-sensitive G proteins regulate lymphoid lineage specification in multipotent hematopoietic progenitors |
| Q26830824 | Pivotal roles of GM-CSF in autoimmunity and inflammation |
| Q33703008 | Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis |
| Q51713983 | Potential roles of extracellular signal-regulated kinase but not p38 during myeloid differentiation of U937 cells stimulated by cytokines: augmentation of differentiation via prolonged activation of extracellular signal-regulated kinase. |
| Q37175923 | Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture |
| Q84773120 | Protection against Nippostrongylus brasiliensis infection in mice is independent of GM-CSF |
| Q36470632 | Protein microarrays identify disease-specific anti-cytokine autoantibody profiles in the landscape of immunodeficiency |
| Q38924994 | Pulmonary Alveolar Proteinosis Syndrome |
| Q95410224 | Pulmonary alveolar proteinosis |
| Q53210676 | Pulmonary alveolar proteinosis as an unusual pattern of lung involvement in Sjögren syndrome. |
| Q36979986 | Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. |
| Q49351201 | Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach |
| Q33774873 | Pulmonary alveolar proteinosis in children on La Réunion Island: a new inherited disorder? |
| Q43358363 | Pulmonary alveolar proteinosis secondary to Pneumocystis jiroveci infection in an infant with common variable immunodeficiency |
| Q35795061 | Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice |
| Q64123181 | Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association |
| Q34365898 | Pulmonary alveolar proteinosis: a review |
| Q34115410 | Pulmonary alveolar proteinosis: an overview for internists and hospital physicians |
| Q24679404 | Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis |
| Q38041659 | Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges |
| Q34139014 | Pulmonary alveolar proteinosis: progress in the first 44 years |
| Q38416755 | Pulmonary alveolar proteinosis: time to shift? |
| Q39759848 | Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice |
| Q34539736 | Pulmonary macrophage transplantation therapy |
| Q41416064 | Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung |
| Q45867818 | Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis |
| Q34660473 | RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. |
| Q37181748 | Rare lung disease II: pulmonary alveolar proteinosis. |
| Q34520707 | Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin |
| Q36449773 | Redefining Myeloid Cell Subsets in Murine Spleen |
| Q34989547 | Reduced number and morphofunctional change of alveolar macrophages in MafB gene-targeted mice |
| Q40637210 | Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor |
| Q37061451 | Regulation of postnatal lung development and homeostasis by estrogen receptor beta. |
| Q34138184 | Regulatory pathways in blood-forming tissue with particular reference to gap junctional communication |
| Q41849470 | Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions |
| Q47319432 | Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages |
| Q43107256 | Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients |
| Q55239888 | Rituximab for auto-immune alveolar proteinosis, a real life cohort study. |
| Q42638867 | Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during Mycobacterium tuberculosis Infection |
| Q36705885 | Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge |
| Q43179240 | Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa. |
| Q35746087 | Role of granulocyte/macrophage colony-stimulating factor in zymocel-induced hepatic granuloma formation |
| Q42789370 | Role of interferon-gamma in interleukin 12-induced pathology in mice. |
| Q89168207 | Safety testing of monoclonal antibodies in non-human primates: Case studies highlighting their impact on human risk assessment |
| Q41399533 | Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: lessons from mouse knockouts |
| Q24557526 | Selective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiation |
| Q30306581 | Severe inflammatory defect and reduced viability in CD18 and E-selectin double-mutant mice |
| Q90103848 | Siglec-F is induced by granulocyte-macrophage colony-stimulating factor and enhances interleukin-4-induced expression of arginase-1 in mouse macrophages |
| Q33943220 | Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family. |
| Q28390164 | Spontaneous pulmonary alveolar proteinosis in captive "moustached tamarins" (Saguinus mystax) |
| Q35946169 | Spontaneous retrotransposon insertion into TNF 3'UTR causes heart valve disease and chronic polyarthritis |
| Q78127510 | Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease |
| Q38988087 | Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date |
| Q48150411 | Stat5 Is Required for CD103+ Dendritic Cell and Alveolar Macrophage Development and Protection from Lung Injury. |
| Q41672860 | Surfactant protein B deficiency: insights into inherited disorders of lung cell metabolism |
| Q35143717 | Susceptibility to tuberculosis: A locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs |
| Q38284004 | Systems approach to phagocyte production and activation: neutrophils and monocytes |
| Q36823006 | T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice |
| Q42189381 | T-cell-restricted T-bet overexpression induces aberrant hematopoiesis of myeloid cells and impairs function of macrophages in the lung |
| Q33959954 | Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. |
| Q38657999 | Targeting GM-CSF in inflammatory diseases |
| Q41581562 | Targeting cholesterol homeostasis in lung diseases |
| Q92515207 | The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development? |
| Q34304678 | The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling |
| Q91708004 | The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game |
| Q33785115 | The beta common chain (beta c) of the granulocyte macrophage-colony stimulating factor, interleukin-3 and interleukin-5 receptors |
| Q35936937 | The colony-stimulating factors and cancer |
| Q38964911 | The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis |
| Q37306641 | The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease |
| Q52197712 | The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. |
| Q89403485 | The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities |
| Q33835843 | The molecular basis of pulmonary alveolar proteinosis |
| Q52827187 | The multi-organ origin of interleukin-5 in the mouse. |
| Q50045576 | The neutrophil: one cell on many missions or many cells with different agendas? |
| Q37362027 | The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis |
| Q42098813 | The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation |
| Q41228239 | The role of cytokines in functional regulation and differentiation of dendritic cells |
| Q82708004 | The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation |
| Q33657643 | The toxicology of interleukin-12: a review |
| Q30491770 | The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis. |
| Q39005333 | The use of growth factors and other humoral agents to accelerate and enhance burn wound healing |
| Q37774483 | Therapy options in pulmonary alveolar proteinosis. |
| Q34650719 | Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes |
| Q36829147 | Trophic macrophages in development and disease |
| Q101226373 | Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis |
| Q58780462 | Von Hippel-Lindau Protein Is Required for Optimal Alveolar Macrophage Terminal Differentiation, Self-Renewal, and Function |
| Q73047187 | [GM-CSF: a therapeutic alternative to the bronchoalveolar lavage in the treatment of alveolar proteinosis] |
Search more.